Sarah Hassan

Sarah Hassan is a seasoned professional with extensive experience in the healthcare investment and pharmaceutical sectors. Currently serving as the Managing Partner at Dynagrow Capital since August 2010, Sarah Hassan focuses on investing in innovation-centered healthcare companies. In addition to this role, Sarah Hassan is a Board Member at Vinci Pharmaceuticals, Inc. and PleoPharma, and operates Welmedix. Previously, Sarah Hassan held the position of Partner at Caerus Ventures and served as CFO at IM HealthScience. Educationally, Sarah Hassan earned an MBA in Finance & Pharmaceutical Management and a Bachelor of Science in Entrepreneurship/Entrepreneurial Studies from Fairleigh Dickinson University-Florham Campus.